middl
east
respiratori
syndrom
coronaviru
merscov
caus
acut
sever
lower
respiratori
ill
well
vomit
diarrhea
renal
failur
licens
merscov
vaccin
current
avail
prevent
therapeut
measur
urgent
need
surfac
spike
glycoprotein
merscov
bind
cellular
receptor
dipeptidyl
peptidas
consid
major
target
merscov
vaccin
develop
design
recombin
replicationdefici
adenovirusbas
vaccin
express
ntermin
domain
radntd
receptorbind
domain
radrbd
merscov
subunit
fulllength
spike
protein
radspik
found
immun
candid
vaccin
via
intranas
rout
induc
igg
antibodi
neutral
antibodi
mer
spike
pseudotyp
viru
especi
rad
spike
induc
highest
neutral
antibodi
titer
strongest
cytokineinduc
cell
respons
among
three
candid
vaccin
compar
immun
respons
induc
differ
administr
rout
radspik
administ
via
intranas
sublingu
intramuscular
rout
administr
rout
exhibit
neutral
effect
serum
merscovspecif
neutral
iga
antibodi
bronchoalveolar
lavag
fluid
induc
intranas
sublingu
administr
intramuscular
administr
intranas
administr
radspik
also
creat
resid
memori
cell
airway
lung
parenchyma
taken
togeth
result
show
humor
cellular
immun
respons
highli
induc
radspik
administr
suggest
radspik
may
confer
protect
merscov
infect
open
access
citat
kim
mh
kim
hj
chang
j
superior
immun
respons
induc
intranas
immun
recombin
adenovirusbas
vaccin
express
fulllength
spike
protein
middl
east
respiratori
syndrom
coronaviru
plo
one
http
doiorg
middl
east
respiratori
syndrom
coronaviru
merscov
emerg
novel
lethal
human
pathogen
caus
sever
acut
respiratori
infect
sinc
identif
plo
one
http
juli
saudi
arabia
viru
caus
respiratori
diseas
fever
cough
short
breath
may
lead
pneumonia
acut
renal
failur
immunocompromis
patient
elderli
date
laboratoryconfirm
merscov
infect
case
includ
relat
death
countri
report
world
health
organ
http
wwwwhointemergenciesmerscoven
current
case
increasingli
report
merscov
also
potenti
widespread
outbreak
observ
south
korea
current
lack
prophylact
therapeut
measur
creat
urgent
need
effect
vaccin
develop
merscov
infect
merscov
envelop
positivesens
singlestrand
rna
viru
belong
lineag
c
genu
betacoronaviru
famili
coronavirida
merscov
genom
encod
four
structur
protein
spike
envelop
e
membran
nucleocapsid
n
protein
type
transmembran
glycoprotein
viru
surfac
contain
two
function
subunit
mediat
viral
infect
subunit
compris
ntermin
domain
ntd
receptorbind
domain
rbd
recogn
bind
dipeptidyl
peptidas
also
known
receptor
host
cell
surfac
initi
infect
subunit
two
heptad
repeat
hr
facilit
fusion
viru
host
cell
membran
glycoprotein
consid
suitabl
vaccin
candid
elicit
neutral
antibodi
block
viral
entri
neutral
viral
infect
spike
proteinbas
vaccin
candid
develop
investig
wholeinactiv
viru
subunit
vaccin
dnabas
vaccin
viral
vectorbas
vaccin
use
spike
protein
whole
spike
protein
fragment
vaccin
candid
induc
humor
immun
respons
neutral
antibodi
respons
well
cellular
immun
respons
howev
vaccin
strategi
focus
rbd
alon
sever
issu
may
optim
gener
neutral
antibodi
respons
induc
partial
protect
merscov
infect
detail
structur
analysi
reveal
rbdspecif
antibodi
stimul
emerg
viral
escap
mutat
region
therefor
gener
divers
antibodi
direct
toward
rbd
outsid
domain
may
better
strategi
develop
effect
vaccin
design
construct
recombin
adenovirusbas
vaccin
candid
encod
ntd
rbd
fulllength
spike
protein
assess
immunogen
compar
immun
respons
gener
vaccin
via
differ
rout
found
radspik
could
induc
strongest
humor
cellular
immun
respons
addit
immun
radspik
confer
longlast
neutral
antibodi
respons
suggest
radspik
best
candid
effect
merscov
vaccin
develop
femal
balbc
mice
age
week
purchas
orient
bio
inc
seoul
korea
mice
maintain
specif
pathogenfre
condit
experiment
facil
ewha
woman
univers
mice
group
hous
cage
contain
four
mice
approxim
h
lightdark
cycl
cage
chang
perform
weekli
end
experi
food
water
replenish
need
studi
mice
check
daili
ensur
health
anim
welfar
mice
sacrif
co
euthanasia
anim
studi
approv
ewha
woman
univers
institut
anim
care
use
committe
iacuc
approv
carri
strict
complianc
suggest
given
institut
laboratori
anim
resourc
guid
care
use
laboratori
anim
cell
atcc
cultur
mem
welgen
korea
contain
fetal
bovin
serum
fb
cell
cell
purchas
atcc
collect
manassa
va
grown
dmem
welgen
supplement
fb
spodoptera
frugiperda
insect
cell
invitrogen
carlsbad
ca
usa
propag
ii
serumfre
medium
gibco
brl
use
produc
recombin
ntd
rntd
protein
normal
human
nasal
epitheli
nhne
cell
cultur
describ
previous
briefli
nhne
cell
cellscultur
seed
ml
cultur
medium
transwel
clear
cultur
insert
pore
size
costar
co
cambridg
usa
cell
cultur
mixtur
basal
epitheli
growth
medium
dmem
contain
previous
describ
supplement
cultur
grown
submerg
first
day
cultur
medium
chang
day
everi
day
thereaft
airliquid
interfac
ali
creat
day
remov
apic
medium
feed
cultur
basal
compart
cultur
medium
chang
daili
initi
ali
add
antibiot
penicillin
streptomycin
media
subcultur
cultur
stage
also
add
antifung
agent
fungizon
ml
ml
media
life
technolog
grand
island
ny
usa
filter
media
experi
describ
use
cultur
nasal
epitheli
cell
day
creation
ali
amino
acid
sequenc
merscov
spike
protein
merscovkorknih
genbank
residu
spike
gene
codonoptim
synthes
mammalian
cell
express
genscript
piscataway
nj
optim
kozak
translat
sequenc
also
includ
immedi
upstream
atg
synthet
dna
subclon
pshuttlecmv
vector
bgliinoti
doubl
digest
use
templat
polymeras
chain
reaction
pcr
amplif
subsequ
construct
express
differ
merscov
spike
protein
fragment
design
code
sequenc
rbd
residu
amplifi
pcr
use
forward
revers
primer
contain
two
stop
codon
flag
tag
sequenc
code
sequenc
ntd
residu
amplifi
pcr
use
forward
revers
primer
contain
two
stop
codon
sixhistidin
tag
sequenc
final
pcr
product
rbd
ntd
gene
insert
pshuttlecmv
vector
nheixhoi
doubl
digest
respect
pshuttlecmv
plasmid
design
includ
start
codon
signal
sequenc
human
tissu
plasminogen
activ
tpa
upstream
transgen
sequenc
replicationdefect
adenovirus
serotyp
gener
insert
foreign
sequenc
via
homolog
recombin
subsequ
purif
recombin
adenoviru
rad
describ
previous
briefli
shuttl
vector
plasmid
electropor
electrocompet
cell
carri
adenovir
genom
dna
recombin
adenovir
dna
isol
linear
paci
subsequ
transfect
cell
gener
radspik
radrbd
radntd
virus
mock
adenoviru
radmock
gener
method
use
empti
pshuttlecmv
vector
recombin
virus
amplifi
cell
purifi
doublecesium
chlorid
cscl
gradient
ultracentrifug
express
secret
spike
rbd
protein
radinfect
cell
verifi
via
western
blot
analysi
employ
antimerscov
protein
rabbit
polyclon
antibodi
amino
acid
aa
sino
biolog
inc
beij
china
hrpconjug
goat
antirabbit
igg
antibodi
abcam
cambridg
uk
express
secret
ntd
protein
valid
infect
cell
conduct
western
blot
analysi
use
radspikeimmun
mous
serum
dilut
hrpconjug
rabbit
antimous
igg
antibodi
abcam
secondari
antibodi
femal
balbc
mice
age
week
immun
rad
vaccin
control
viru
via
intranas
intramuscular
im
sublingu
sl
rout
immun
mice
lightli
anesthet
via
isofluran
ifran
hana
pharm
kyonggido
korea
inhal
vaccin
control
viru
solut
inocul
left
nostril
im
immun
vaccin
inject
right
hind
leg
mice
sl
immun
mice
anesthet
intraperiton
ip
inject
mgkg
bodi
weight
ketamin
yuhan
co
seoul
korea
mgkg
bodi
weight
rompun
bayer
seoul
korea
mixtur
pb
subsequ
vaccin
inocul
tongu
blood
collect
retroorbit
plexu
use
heparin
capillari
tube
blood
sampl
centrifug
sera
obtain
store
mice
sacrif
week
undergo
last
immun
tracheotomi
perform
bronchoalveolar
lavag
fluid
balf
collect
wash
lung
airway
ml
pb
balf
centrifug
supernat
use
measur
secretori
iga
neutral
antibodi
titer
rntd
protein
prepar
use
bactobac
baculoviru
express
system
invitrogen
accord
manufactur
protocol
ntd
gene
amplifi
pcr
describ
clone
vector
tpa
protein
secret
express
cassett
insert
baculoviru
genom
within
invitrogen
recombin
bacmidencod
ntd
rbacntd
plasmid
transfect
cell
use
cellfectin
transfect
reagent
invitrogen
primari
recombin
baculoviru
harvest
day
transfect
amplifi
infect
new
largescal
cell
cultur
obtain
rntd
protein
final
cultur
supernat
infect
cell
collect
load
onto
histrap
hp
column
ge
healthcar
bind
buffer
mm
kpo
mm
nacl
mm
imidazol
ph
column
wash
bind
buffer
elut
use
elut
buffer
mm
kpo
mm
nacl
mm
imidazol
ph
remov
impur
elut
target
protein
fraction
pool
concentr
bufferexchang
pb
purifi
rntd
protein
concentr
determin
use
nanodrop
spectrophotomet
thermo
fisher
scientif
antigenspecif
igg
iga
antibodi
titer
immun
mice
determin
direct
enzymelink
immunosorb
assay
elisa
briefli
plate
nunc
maxisorp
thermo
fisher
scientif
coat
ngwell
aa
aa
rbd
aa
sino
biolog
inc
rntd
aa
merscov
spike
protein
pb
incub
overnight
antigenco
well
block
pb
contain
nonfat
milk
tween
h
room
temperatur
rt
subsequ
serial
dilut
sera
balf
ad
well
incub
h
rt
wash
pb
contain
tween
hrpconjug
rabbit
antimous
igg
abcam
hrpconjug
goat
antimous
iga
zyme
laboratori
san
francisco
ca
ad
secondari
antibodi
incub
h
rt
dark
condit
plate
wash
reaction
develop
tmb
peroxidas
substrat
kpl
gaithersburg
md
gradual
reaction
stop
h
po
analyz
nm
wavelength
use
thermo
multiskan
ex
vantaa
finland
gfpexpress
lentivir
transfer
plasmid
construct
use
gateway
vector
kit
invitrogen
accord
manufactur
protocol
fulllength
merscov
spike
proteinexpress
envelop
plasmid
construct
insert
codonoptim
synthet
dna
sequenc
genscript
pcagg
plasmid
addgen
wwwaddgeneorg
produc
merscov
spike
pseudotyp
lentiviru
cell
cotransfect
packag
plasmid
lentivir
transfer
plasmid
envelop
plasmid
pcaggmerscov
spike
use
lipofectamin
transfect
regent
invitrogen
overnight
incub
transfect
medium
replac
fresh
dmem
fortyeight
hour
later
cultur
supernat
contain
pseudoviru
collect
centrifug
remov
debri
pass
filter
store
huh
cell
cell
per
well
plate
plate
day
neutral
assay
sera
balf
heatinactiv
min
merscov
spike
pseudoviru
preincub
serial
dilut
sera
balf
h
mixtur
ad
huh
cell
overnight
incub
cell
chang
fresh
dmem
cultur
anoth
h
subsequ
cell
harvest
trypsinedta
analyz
use
facscalibur
flow
cytomet
bd
bioscienc
san
diego
ca
merscov
pseudoviru
transduct
measur
transduct
nhne
cell
infect
viru
solut
merscov
ml
korea
center
diseas
control
prevent
korea
day
total
rna
isol
use
trizol
life
technolog
seoul
korea
cdna
synthes
rna
random
hexam
primer
moloney
murin
leukemia
viru
revers
transcriptas
perkin
elmer
life
scienc
waltham
usa
roch
appli
scienc
indianapoli
usa
amplif
perform
use
taqman
univers
pcr
master
mix
pe
biosystem
foster
citi
ca
usa
accord
manufactur
protocol
briefli
amplif
reaction
total
volum
contain
cdna
revers
transcript
mixtur
oligonucleotid
primer
final
concentr
nm
taqman
hybrid
probe
nm
realtim
pcr
probe
label
end
carboxyfluorescein
fam
end
quencher
carboxytetramethylrhodamin
tamra
quantifi
cellular
viral
level
host
gene
express
cellular
rna
use
gener
cdna
merscov
mrna
level
monitor
use
quantit
pcr
gene
mer
primer
gene
merscov
purchas
appli
biosystem
foster
citi
ca
usa
realtim
pcr
perform
use
pe
biosystem
abi
prism
sequenc
detect
system
thermocyl
paramet
follow
min
min
cycl
min
pcr
assay
quantit
util
plasmid
contain
target
gene
sequenc
standard
reaction
perform
triplic
realtim
pcr
data
normal
level
housekeep
gene
glyceraldehyd
phosphat
dehydrogenas
gapdh
copi
correct
variat
sampl
use
syring
lung
perfus
ml
pb
contain
uml
heparin
sigma
st
loui
mo
via
right
ventricl
obtain
singlecel
suspens
tissu
homogen
pass
cell
strainer
spl
kyonggido
korea
mhc
class
tetram
analysi
lymphocyt
wash
fac
buffer
fb
pb
block
purifi
rat
antimous
bd
pharmingen
san
diego
ca
streptavidin
invitrogen
cell
stain
biolegend
san
diego
ca
k
kyysiiphsi
tetram
min
dark
condit
stain
cell
fix
fac
lyse
solut
bd
bioscienc
evalu
cytokineproduc
cell
intracellular
stain
perform
lung
lymphocyt
resuspend
iscov
modifi
dulbecco
medium
imdm
welgen
supplement
fb
stimul
mer
peptid
kyysiiphsi
mer
protein
aa
sino
biolog
inc
presenc
brefeldin
ebiosci
san
diego
ca
recombin
human
biolegend
h
stimul
cell
initi
stain
lymphocyt
isol
lung
spleen
describ
previous
subsequ
cell
stain
biolegend
k
tetram
identifi
dead
cell
cell
fix
subsequ
stain
dapi
biolegend
min
rt
analysi
flow
cytomet
data
stain
cell
acquir
use
bd
lsr
fortessa
bd
bioscienc
analyz
use
flowjo
softwar
treestar
inc
ashland
data
present
mean
standard
error
mean
sem
n
statist
differ
two
mean
analyz
use
twotail
student
test
comparison
multipl
group
oneway
analysi
varianc
anova
twoway
anova
along
bonferroni
posttest
use
appropri
statist
signific
consid
p
valu
design
gener
three
recombin
adenovirus
vaccin
candid
contain
codonoptim
fulllength
spike
rbd
ntd
region
spike
code
sequenc
fulllength
spike
rbd
ntd
clone
shuttl
vector
control
cytomegaloviru
cmv
promot
subsequ
insert
adenoviru
genom
via
homolog
recombin
construct
scheme
recombin
replicationdefect
adenovirus
design
radspik
radrbd
rad
ntd
shown
fig
confirm
transgen
express
cell
infect
radspik
radrbd
radntd
western
blot
perform
western
blot
perform
use
merscov
antibodi
reveal
two
promin
band
kda
kda
cultur
supernat
lysat
radspikeinfect
cell
fig
consid
protein
speci
higher
molecular
weight
kda
glycosyl
spike
protein
speci
lower
molecular
weight
kda
subunit
spike
protein
cleav
host
cell
proteas
rbd
domain
detect
singl
band
molecular
weight
kda
lysat
cultur
supernat
radrbdinfect
cell
fig
molecular
weight
rbd
increas
slightli
cultur
supernat
might
due
differ
pattern
glycosyl
cultur
supernat
lysat
singl
band
kda
observ
cultur
supernat
radntdinfect
cell
inhous
rad
spikeimmun
mous
serum
fig
compar
immunogen
recombin
adenovir
vaccin
candid
balbc
mice
immun
twice
day
day
radntd
radrbd
radspik
control
adenoviru
radmock
via
rout
mice
sacrif
day
boost
immun
analyz
humor
cellular
immun
respons
candid
vaccin
induc
signific
system
igg
respons
sera
oppos
neg
control
radmock
vaccin
fig
notabl
radspikeimmun
group
induc
highest
serum
igg
respons
among
three
group
mucos
iga
respiratori
tract
play
critic
role
host
defens
respiratori
viru
infect
thu
measur
spikespecif
mucos
iga
antibodi
respons
balf
iga
detect
vaccin
group
control
group
fig
among
three
vaccin
group
radspik
group
elicit
highest
level
iga
respons
radntd
group
show
higher
titer
shown
radrbd
group
next
examin
abil
candid
vaccin
induc
cellular
immun
respons
mice
sacrif
day
boost
inject
peak
tcell
respons
lung
cell
harvest
lung
lymphocyt
stain
k
tetram
quantifi
spikespecif
cell
previou
studi
report
tcell
respons
merscov
spike
protein
dominantli
direct
toward
kyysiiphsi
epitop
studi
also
screen
epitop
rbd
region
measur
antigenspecif
tcell
respons
frequenc
cell
respond
peptid
seem
either
undetect
low
therefor
employ
immunodomin
epitop
evalu
spikespecif
tcell
respons
signific
percentag
k
tetramerposit
cell
detect
lung
radntdor
radspikeimmun
mice
lung
mice
radmock
radrbd
group
fig
cell
observ
radrbdimmun
mice
rbd
aa
residu
contain
epitop
assess
level
effector
cell
secret
lung
lymphocyt
stimul
peptid
mer
protein
respect
cell
also
increas
significantli
radspik
radntd
group
cell
increas
significantli
radspik
group
fig
subsequ
neutral
activ
immun
sera
balf
evalu
use
merscov
spike
pseudotyp
particl
among
candid
vaccin
group
rad
spikeimmun
mice
exhibit
highest
level
neutral
antibodi
sera
balf
follow
mice
radntd
group
fig
howev
radrbd
group
exhibit
signific
differ
neutral
activ
compar
radmock
control
group
confirm
neutral
activ
radspikeinduc
antibodi
authent
merscov
infect
human
primari
respiratori
cell
merscov
preincub
immun
sera
radspik
radmock
group
infect
nhne
cell
subsequ
viral
replic
level
measur
quantit
rtpcr
shown
fig
pretreat
radspikeimmun
sera
significantli
inhibit
merscov
replic
radmock
sera
taken
togeth
result
demonstr
immun
radspik
effici
elicit
neutral
antibodi
respons
serum
balf
tcell
respons
recent
studi
shown
neutral
antibodi
could
also
direct
nonrbd
ntd
besid
rbd
result
also
indic
ntd
elicit
neutral
antibodi
respons
immun
therefor
investig
region
specif
neutral
activ
induc
immun
rad
vaccin
first
serum
igg
respons
analyz
elisa
use
ntd
rbd
protein
coat
antigen
rntd
protein
prepar
purifi
use
baculoviru
express
system
fig
radntd
radspik
group
exhibit
significantli
higher
level
ntdspecif
serum
igg
control
group
signific
differ
ntdspecif
serum
igg
level
radntd
radspik
group
fig
rad
rbd
radspik
group
exhibit
significantli
higher
level
rbdspecif
serum
igg
neg
control
group
fig
expect
radspik
group
show
significantli
higher
serum
igg
respons
control
group
fig
investig
target
domain
mainli
involv
neutral
compar
chang
neutral
activ
sera
collect
radspik
group
use
protein
competitor
sera
dilut
preincub
ntd
rbd
protein
h
neutral
assay
subsequ
perform
shown
fig
shown
fig
neutral
activ
immun
sera
significantli
reduc
preincub
ntd
rbd
protein
competitor
especi
competit
protein
inhibit
neutral
activ
ntd
rbd
competitor
inhibit
neutral
activ
respect
contrast
solubl
protein
competitor
effect
neutral
activ
result
demonstr
radspik
induc
neutral
antibodi
respons
target
variou
region
includ
ntd
rbd
also
suggest
employ
radspik
might
better
vaccin
strategi
elicit
broader
spectrum
neutral
antibodi
respons
previous
show
among
vaccin
candid
radspik
possess
strongest
immunogen
induc
humor
cellular
immun
respons
investig
best
rout
immun
inject
mice
radspik
via
im
sl
rout
sera
collect
week
immun
measur
specif
igg
elisa
signific
spikespecif
igg
level
detect
regardless
immun
rout
fig
notabl
immun
induc
highest
igg
antibodi
respons
among
group
boost
immun
signific
spikespecif
iga
level
detect
balf
mice
sl
group
im
group
fig
respons
also
highest
group
investig
whether
immun
rout
affect
neutral
antibodi
respons
neutral
activ
sera
balf
collect
group
analyz
use
pseudotyp
viru
immun
rout
gener
signific
serumneutr
antibodi
level
oppos
radmock
control
group
fig
howev
neutral
activ
observ
balf
mice
immun
via
im
rout
find
consist
mucos
iga
respons
shown
fig
ic
neutral
titer
show
statist
signific
differ
sl
immun
taken
togeth
result
indic
mucos
immun
radspik
vaccin
induc
system
mucos
neutral
antibodi
im
immun
could
elicit
system
respons
investig
influenc
immun
rout
establish
lung
rm
cell
balbc
mice
administ
im
vaccin
contain
radspik
concentr
pfu
memori
time
point
day
mice
intraven
inject
antibodi
sacrif
min
discrimin
circul
cell
lungloc
cell
shown
fig
cell
stain
ab
identifi
circul
cell
blood
cell
protect
vivo
label
confin
lung
parenchyma
time
point
mice
immun
via
rout
significantli
higher
frequenc
number
k
tetramerposit
cell
airway
lung
parenchyma
compar
imimmun
mice
fig
contrast
signific
differ
number
k
tetramerposit
cell
lung
vasculatur
spleen
im
immun
group
subsequ
assess
coexpress
canon
maker
lung
rm
major
k
tetramerposit
cell
airway
lung
parenchyma
inimmun
mice
frequenc
significantli
higher
imimmun
mice
fig
taken
togeth
result
show
immun
effici
establish
antigenspecif
rm
cell
airway
lung
parenchyma
im
immun
persist
mainten
immun
respons
follow
vaccin
import
vaccin
efficaci
thu
assess
whether
radspik
immun
could
induc
long
term
antibodi
respons
balbc
mice
inocul
three
time
week
pfu
radspik
via
rout
sera
collect
week
specif
antibodi
respons
subsequ
measur
elisa
fig
spikespecif
serum
igg
mucos
iga
titer
gradual
increas
immun
maintain
week
obviou
declin
fig
evalu
neutral
activ
assay
perform
use
sera
collect
week
well
balf
obtain
week
agreement
igg
respons
serum
neutral
activ
week
similar
week
fig
absolut
titer
neutral
balf
week
lower
earlier
time
point
shown
fig
remain
signific
level
comparison
control
fig
overal
result
demonstr
immun
radspik
could
induc
longlast
neutral
antibodi
might
benefici
protect
merscov
infect
sinc
emerg
spread
mer
develop
safe
effect
vaccin
merscov
urgent
requir
merscov
spike
protein
main
mediat
viru
entri
target
cell
therefor
spike
protein
one
key
target
develop
vaccin
therapeut
sever
vaccin
candid
target
rbd
spike
protein
investig
howev
seem
efficaci
rbdbase
vaccin
candid
limit
confin
breadth
antibodi
respons
subsequ
emerg
escap
mutant
inde
shown
sever
mutat
rbd
region
result
gener
neutral
escap
variant
sever
studi
report
region
spike
protein
rather
rbd
also
target
neutral
antibodi
studi
construct
adenovirusbas
vaccin
candid
express
ntd
rbd
fulllength
spike
compar
immunogen
neutral
activ
induc
candid
result
clearli
show
radspik
vaccin
express
fulllength
spike
protein
best
candid
term
immunogen
neutral
efficaci
like
neutral
epitop
spike
protein
locat
nonrbd
subunit
well
rbd
base
result
protein
competitor
experi
fig
use
fulllength
spike
immunogen
radspik
vaccin
might
increas
breadth
antibodi
respons
help
reduc
risk
escap
mutat
howev
yet
clear
whether
region
also
contribut
induc
neutral
antibodi
radspik
vaccin
subunit
protein
competitor
reduc
neutral
activ
immun
sera
protein
competitor
experi
fig
might
due
inappropri
conform
subunit
studi
need
determin
whether
subunit
also
contribut
elicit
neutral
antibodi
noteworthi
radspik
vaccin
induc
system
igg
mucos
iga
tcell
respons
togeth
upon
immun
addit
neutral
antibodi
virusspecif
cell
also
play
import
role
merscov
clearanc
inde
sever
studi
suggest
virusneutr
antibodi
cytotox
cell
respons
necessari
complet
protect
merscov
infect
therefor
radspik
vaccin
express
fulllength
spike
protein
rather
rbd
ntd
alon
might
potent
one
among
vaccin
candid
result
also
demonstr
immun
induc
superior
respons
compar
im
sl
immun
term
neutral
efficaci
merscov
infect
occur
respiratori
tract
human
accordingli
vaccin
rout
capabl
induc
local
mucos
immun
secretori
iga
would
potent
prevent
merscov
infect
addit
immun
radspik
vaccin
induc
significantli
higher
number
specif
rm
cell
airway
lung
parenchyma
compar
imimmun
mice
fig
like
lungresid
rm
cell
mediat
effect
protect
immun
respiratori
infect
thu
immun
radspik
elicit
system
igg
secretori
iga
rm
respons
togeth
might
promis
regimen
compar
immun
rout
provid
superior
protect
summari
gener
sever
recombin
adenovirusbas
vaccin
candid
merscov
compar
system
local
humor
respons
cellular
respons
via
differ
immun
rout
found
singl
immun
rad
spike
success
induc
system
igg
secretori
iga
lung
rm
respons
provid
longlast
neutral
immun
therefor
recombin
adenovirusbas
vaccin
